(8R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol

CAS: 53910-25-1

Ref. AN-AG0038O6

Información del producto

• Nombre: (8R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
• Sinónimos: [u"2' Deoxycoformycin", u"2'-Deoxycoformycin", u'CI 825', u'CI-825', u'CI825', u'Co-vidarabine', u'Deoxycoformycin', u'Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-', u'Nipent', u'NSC 218321', u'NSC-218321', u'NSC218321', u'Pentostatin', u'pentostatin', u'Deoxycoformycin', u'Nipent', u'53910-25-1', u"2'-Deoxycoformycin", u'Covidarabine', u'CO-Vidarabine', u'Pentostatina', u'Pentostatine', u'Pentostatinum', u'Vidarbine', u"2'-Dexoycoformycin", u"2'-DCF", u'Co-V', u'PD-ADI', u'UNII-395575MZO7', u'Vira A deaminase inhibitor', u'YK-176', u'CI-825', u'Coforin', u'PD-81565', u'NSC-218321', u'(R)-Deoxycoformycin', u'395575MZO7', u'(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol', u'NCGC00182045-01', u"8R-2'-Deoxycoformycin", u"(R)-2'-Deoxycoformycin", u'Deaminase inhibitor (PD)', u'dCF', u'NSC 218321', u'Pentostatine [INN-French]', u'Pentostatinum [INN-Latin]', u'Pentostatina [INN-Spanish]', u'(8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol', u'HSDB 6547', u'Pentostatin [USAN:INN:BAN:JAN]', u'BRN 1223097', u'PD 81565', u'(R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol', u'CL 67310465', u'Deaminase, inhibitor for adenosine arabinoside', u'Pentostatn', u'Pentostatin (JAN/USAN/INN)', u'(R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol', u'(R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol', u'Pentostatin (PTN)', u'DSSTox_CID_3436', u'CL-67310465', u'AC1L97UQ', u'Pentostatin(Deoxycoformycin)', u'SCHEMBL2817', u'CHEMBL1580', u'DSSTox_RID_77027', u'DSSTox_GSID_23436', u'BIDD:GT0136', u'GTPL4805', u'DTXSID2023436', u'BDBM22925', u'Pentostatin, >=95% (HPLC)', u'FPVKHBSQESCIEP-JQCXWYLXSA-N', u'BDBM223291', u'HY-A0006', u'Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-', u'ZINC3806262', u'Tox21_113417', u'MFCD00078802', u'AKOS024456918', u'AKOS032949742', u'API0005275', u'CS-0374', u'DB00552', u'PB12063', u'RL03997', u'NCGC00388420-02', u'(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol', u'Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-', u'AB0010579', u'CAS-53910-25-1', u'A3708', u'C02267', u'D00155', u'EN300-222177', u'Q-4464', u'910P251', u'SR-01000883935', u'J-523899', u'SR-01000883935-1', u'Z2216208604', u'(8R)-3-(2-Deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol', u'(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol', u'(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol', u'(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-8-ol'], (8R)-3-(2-Deoxy-β-<span class="text-smallcaps">D</span>-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, (8R)-3-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-f][1,3]diazepin-8-ol, (R)-3-(2-Deoxy-Beta-D-Erythro-Pento-Furanosyl)-3,6,7,8-Tetrahydroimidazo[4,5-D, (R)-3-(2-Deoxy-Beta-D-Pentofuranosyl)-3,6,7,8-Tetrahydroimidazo(4,5-D)(1,3)D, (R)-Deoxycoformycin, (R)-Rahydro, 2'-Dcf, 2'-Dexoycoformycin, 2’-Deoxycoformycin, 2’Dcf, Ci-825, Cl 67310465, Cl 825, Co-V, Co-Vidarabine, Coforin, Deaminase inhibitor, Deoxycoformycin, Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-<span class="text-smallcaps">D</span>-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-, Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-<span class="text-smallcaps">D</span>-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-, Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-, Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-, Nipent, Nsc 218321, Nsc 247520, Pd-Adi, Vira A deaminase inhibitor
• CAS: 53910-25-1
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 268.2691
• Fórmula: C₁₁H₁₆N₄O₄
• Pureza: 98%
• Color/Forma: Solid
• InChI: InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1
• Clave InChI: FPVKHBSQESCIEP-JQCXWYLXSA-N